Keros Therapeutics, Inc. (KROS)
NASDAQ:KROS
Want to see KROS full AI Analyst Report?
Keros Therapeutics (KROS) Ownership Overview
4.94% Insiders
19.58% Mutual Funds
22.98% Other Institutional Investors
16.83% ETFs
35.68% Public Companies and
Individual Investors
The ownership structure of Keros Therapeutics (KROS) stock is a mix of institutional, retail, and individual investors. Approximately 59.38% of the company’s stock is owned by Institutional Investors, 4.94% is owned by Insiders, and 35.68% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 20, 2026 | xxxxxxxxxxxxx | $113433 | |
Feb 20, 2026 | xxxxxxxxxxxxx | $63324 | |
Feb 20, 2026 | xxxxxxxxxxxxx | $77483 | |
Oct 17, 2025 | xxxxxxxxxxxxx | $84975125 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,189,882 | Institution | 11.06% | 24,066,803 | |
| 1,227,194 | Institution | 6.20% | 13,486,862 | |
| 1,065,957 | Institution | 5.39% | 11,714,867 | |
| 812,711 | Institution | 4.11% | 8,931,694 | |
| 498,518 | Institution | 2.52% | 5,478,713 | |
| 440,708 | Insider | 2.23% | 4,843,381 | |
| 329,731 | Institution | 1.67% | 3,623,744 | |
| 297,624 | Institution | 1.50% | 3,270,888 | |
| 263,238 | Insider | 1.33% | 2,892,986 | |
| 219,621 | Institution | 1.11% | 2,413,635 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 812,711 | Institution | 4.11% | 8,931,694 | |
| 498,518 | Institution | 2.52% | 5,478,713 | |
| 329,731 | Institution | 1.67% | 3,623,744 | |
| 297,624 | Institution | 1.50% | 3,270,888 | |
| 219,621 | Institution | 1.11% | 2,413,635 | |
| 210,962 | Institution | 1.07% | 2,318,472 | |
| 190,089 | Institution | 0.96% | 2,089,078 | |
| 171,150 | Institution | 0.86% | 1,880,939 | |
| 168,517 | Institution | 0.85% | 1,852,002 | |
| 162,294 | Institution | 0.82% | 1,783,611 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 702,212 | Institution | 3.55% | 7,668,155 | |
| 595,316 | Institution | 3.01% | 6,697,305 | |
| 246,783 | Institution | 1.25% | 2,694,870 | |
| 220,854 | Institution | 1.12% | 2,484,608 | |
| 149,903 | Institution | 0.76% | 1,686,409 | |
| 145,517 | Institution | 0.74% | 1,600,687 | |
| 126,092 | Institution | 0.64% | 1,376,925 | |
| 101,848 | Institution | 0.51% | 1,112,180 | |
| 92,909 | Institution | 0.47% | 1,021,999 | |
| 86,247 | Institution | 0.44% | 948,717 |
FAQ
Who Owns Keros Therapeutics, Inc. (KROS)?
According to the latest TipRanks data, approximately 22.98% of the company's stock is held by institutional investors, 4.94% is held by insiders, and 35.68% is held by retail investors.
What percentage of Keros Therapeutics, Inc. (KROS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 22.98% of Keros Therapeutics, Inc. (KROS) stock is held by institutional investors.
What percentage of Keros Therapeutics, Inc. (KROS) stock is held by retail investors?
According to the latest TipRanks data, approximately 35.68% of Keros Therapeutics, Inc. (KROS) stock is held by retail investors.
Who owns the most shares of Keros Therapeutics, Inc. (KROS)?
Eric Andersen owns the most shares of Keros Therapeutics, Inc. (KROS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.